12:36 EDT Alpine Immune jumps 7% to $41.74 after Bloomberg report of takeover interest
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALPN:
- Alpine Immune Sciences initiated with a Buy at Guggenheim
- Alpine Immune Sciences Announces New Chief Accounting Officer
- Biotech Alert: Searches spiking for these stocks today
- Vera Therapeutics price target raised to $34 from $21 at Wedbush
- Alpine Immune Sciences’ Growth at Risk: Navigating FDA and SEC Disruptions Amidst Political and Health Uncertainties
